Abstract
The emergence of antimicrobial resistance (AMR) is an urgent and complex public health challenge worldwide. As a sub-problem of AMR, antibacterial resistance (ABR) is of particular concern due to inadequacy of alternative medication. Earlier studies have shown that ABR is not only impacted by antibiotics, but also affected by the interactions between bacteria and their environments. Therefore, to combat ABR in a specific region, local environmental conditions must be investigated to comprehensively understand which environmental factors might contribute to ABR and propose more tailored solutions. This study surveyed environmental contributors of antibiotic resistance genes (ARGs), the parameter for measuring ABR, in the Yangtze Delta. A high abundance of ARGs was detected, despite low antibiotic and heavy metal concentrations. Phosphorus, chromium, manganese, calcium, and strontium were identified as potential key contributors of ARGs. Suppression of ARGs could be realized through decreasing the concentration of phosphorus in surface water. Group 2A light metals (e.g., magnesium and calcium) could be developed as eco-friendly reagents for controlling antibiotic resistance in the future.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was funded by Interdisciplinary Health Research Fund at the Global Health Research Center, Duke Kunshan University, Kunshan, China.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.